MW
About
Martin Werle has many years of international experience as scientist and project leader in the area of oral peptide delivery, in both, academia and Start-ups. In addition he held various leadership and management positions in formulation development, corporate strategy and global R&D project management at Syngenta AG, Basel, Switzerland. MartinWerle has published more than 30 peer reviewed research articles and book contributions in the field of drug delivery. He received an MBA from SMC University, Switzerland and a PhD in Pharmaceutical Technology from the University of Innsbruck, Austria.
Position in the VCSift Database
- • 248 investors hold the Chief Operating Officer role in VCSift. Martin Werle is one of them.
- • 6 investors are based in Austria, Pangasinan, Philippines.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Austria, Philippines
Contact Information
linkedin.com/in/••••••••
Find more investors like Martin
Search Investors